Skip to content

Feasibility of Cough Skill Training in Individuals With Head and Neck Cancer

Feasibility of Cough Skill Training in Individuals With Head and Neck Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07756684
Enrollment
10
Registered
2026-08-11
Start date
2026-10-01
Completion date
2027-09-01
Last updated
2026-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancers

Keywords

cough skill training

Brief summary

This preliminary study will examine the feasibility of a cough skill training treatment approach to rehabilitate voluntary cough function in people with head and neck cancer. Cough skill training focuses on practicing cough as a compensatory strategy for when food or liquid enters the airway. Primary outcomes will be feasibility and immediate treatment effects. The investigators hypothesize that the treatment will be feasible and will result in improvements to voluntary cough peak expiratory flow rate.

Detailed description

Participants will complete an initial in-person baseline evaluation of voluntary cough function, followed by five weekly telehealth treatment sessions for five weeks with home practice, before completing a post-treatment in-person evaluation. During each treatment session with study personnel and during home practice, they will complete 25 repetitions (5 sets of 5) of voluntary coughs.

Interventions

DEVICEHandheld cough device

During each treatment session with study personnel and during home practice, participants will complete 25 repetitions (5 sets of 5) of a voluntary coughs.

Sponsors

Boston University Charles River Campus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prior diagnosis of head and neck cancer at least 6 months post-diagnosis * Completed treatment for head and neck cancer, including surgery, radiation, or chemotherapy * Medically stable and able to follow commands and produce a voluntary cough * English speaking

Exclusion criteria

* Unable to provide informed consent assessed by a Montreal Cognitive Assessment (MoCA) score of \<20 * Unable to follow study instructions * Unable to produce a voluntary cough * History of neurologic disease * Recent laryngeal surgery or vocal fold injury * Active respiratory infection or febrile illness within the past 14 days * Chronic, severe, or unstable respiratory disease * Asthma or bronchitis * Smoking within the past five years * Uncontrolled hypertension * Recent myocardial infarction, unstable angina, stroke, or hospitalization for heart failure within the past 6 months * Significant uncontrolled arrhythmia

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of cough skill training6 weeksFeasibility of cough skill training will be defined as the percentage of trials completing during treatment sessions.

Secondary

MeasureTime frameDescription
Change in voluntary cough peak expiratory flow ratebaseline, 6 weeksPeak expiratory flow rate is a measure of cough strength. Changes in cough strength from pretraining to post training will be recorded.
Acceptability assessed by the System Usability Scale6 weeksThe System Usability Scale (SUS) is a quick, 10-item questionnaire used to measure how people feel about the ease of use of a product, app, or website. Users reply using a 5-point scale from strongly disagree to strongly agree, resulting in an overall score from 0 to 100, with higher scores associated with greater acceptability.
Satisfaction assessed by the Beck Satisfaction Scale6 weeksThe 5-item satisfaction and acceptability scale used by Beck et al. (2017) measures treatment experience across five domains on a 5-point scale from 1=very unsatisfied to 5=very satisfied. It evaluates technology/tools, treatment tasks, convenience, organization/clinician interaction, and overall treatment satisfaction. Scores can range from 5 to 25 with higher scores associated with greater satisfaction.

Countries

United States

Contacts

CONTACTJames Borders, PhD CCC-SLP
bordersj@bu.edu617-353-3379
PRINCIPAL_INVESTIGATORJames Borders, PhD CCC-SLP

Boston University Charles River Campus

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 12, 2026